Preview

Nephrology (Saint-Petersburg)

Advanced search

DETERMINATION OF URINARY EXCRETION OF MONOCYTE HAEMOATTRACTIVE PROTEIN-1 IN RENAL DISEASES IN CHILDREN

https://doi.org/10.24884/1561-6274-2011-15-2-77-83

Abstract

THE AIM OF THE STUDY - to investigate the features of urinary excretion of MCP-1 in children with various kidney diseases PATIENTS AND METHODS. The study included 25 healthy children, 22 patients with nephrotic syndrome, 19 - with chronic glomerulonephritis with hematuria, 6 - with nephritic syndrome of acute glomerulonephritis, 9 - with acute renal failure, and 2 -with chronic renal failure. Along with traditional methods it was conducted immunological examination including determination of the concentration of serum antibodies (A, F, G,); levels of circulating immune complexes, complement, lymphocyte immunophenotyping. According to the DNA-cytometry of peripheral blood there were assessed ploidy and cell cycle kinetics. The level of MSR-1 in urine was determined by enzyme immunoassay using mono-and polyclonal antibodies (ZAO Vector-Best Novosibirsk). RESULTS. It was established that in the acute period of all forms of renal pathology MCP-1 rise in the urine. As a result of correlation analysis it was revealed association opened the etiopathogenetic mechanisms of disease progression. It was identified criteria to monitor the activity of the process, determine prognosis, treatment strategy and evaluate the effectiveness of therapy. CONCLUSION. Results of the study suggest that detecting the level of urinary excretion of MCP-1 may be used for monitoring process activity and for determining treatment strategy and evaluating the effectiveness of therapy in glomerulonephritis in children.

About the Authors

L. R. KALMETEVA
Республиканская детская клиническая больница, г. Уфа
Russian Federation


R. M. HAYRULLINA
Республиканская детская клиническая больница, г. Уфа
Russian Federation


References

1. Чеботарева НВ, Бобкова ИН, Козловская ЛВ. Молекулярные механизмы интерстициального фиброза при прогрессирующих заболеваниях почек. Нефрология и диализ 2006; (1): 26-35

2. Картамышева НН, Чумакова ОВ, Кучеренко АГ. Некоторые механизмы формирования тубулоинтерстициального компонента при хронических заболеваниях почек. Мед науч и учебно-метод журн 2002; (6): 176-187

3. AmikoGD. Tubulointerstitium as predictor of progression of glomerular diseases. Nephron 1999; 83 (4): 289-295

4. Border WA, Noble NA. Transforming growth factor-в in tissue fibrosis. N Eng J Med 1994; 331: 1286-1292

5. Viedt C, Orth S. Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes? Nephrol Dial Transplant 2002; 17: 2043-2047

6. Wada T, Yokoyama H, Su S, Mukaida N, Iwano M et al. Monitoring urinary levels of Monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int 1996; 49: 761-767

7. Картамышева НН, Сергеева ТВ, Кучеренко АГ. Моноцитарный хемоаттрактивный протеин-1 (МСР-1) в патогенезе изменений тубулоинтерстициальной ткани у детей с хроническим гломерулонефритом. Нефрология и диализ 2005;(4):443-447

8. Wada T, Furuichi K, Segawa C, Shimizu M et al. MIP-1б and MCP-1 contribute crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int 1999; 56: 995-1003

9. Yokoyama H, Wada T, Furuichi K, Segawa C et al. Urinary levels chemokines (MCAFD MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy. J Leukocyte Biol 1998; 63: 493-499

10. Tam FWK, Sanders J-S, George A, Hammad T at al. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol Dial Transplant 2004; 19: 2761-2768


Review

For citations:


KALMETEVA L.R., HAYRULLINA R.M. DETERMINATION OF URINARY EXCRETION OF MONOCYTE HAEMOATTRACTIVE PROTEIN-1 IN RENAL DISEASES IN CHILDREN. Nephrology (Saint-Petersburg). 2011;15(2):77-83. (In Russ.) https://doi.org/10.24884/1561-6274-2011-15-2-77-83

Views: 308


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)